Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.
Aleksandra Bieniek, PharmD
Advertisement
Articles by Aleksandra Bieniek, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Accepts Sandoz Applications for Generic Tirzepatide
2
Amazon, Fleming Initiative Partner to Combat Antimicrobial Resistance
3
Making Medication Management Services Measurable and Visible
4
New ACIP Charter May Potentially Delay Vaccine Recommendations
5